STRABISMUS STUDY

Refractive surgery is safe and effective in patients with strabismus over the longer term, suggests new data presented at the 2013 Irish College of Ophthalmologists Annual Conference in Killarney, Ireland. Stephen Farrell MD, Mater Private Hospital, Dublin, presented the study data, which examined the long-term outcomes and safety of refractive surgery on ocular alignment, motor fusion and stereoacuity in adult patients with accommodative and non-accommodative strabismus.
Refractive surgery in this cohort usually carries greater risk, particularly in relation to decompensation of ocular alignment over time, thus careful patient selection is vital. Under the Irish study, all patients with manifest strabismus undergoing refractive surgery, including LASIK, LASEK or phakic intraocular lens (IOL) insertion, over a 27-month period at a single centre were included. Patients with best-corrected visual acuity (BCVA) of worse than 6/18 in either eye, a greater than two dioptre change in refraction following cycloplegia, and those unavailable for long-term follow up were excluded, Dr Farrell said.
This left 14 patients in the study, who had a mean follow-up duration of 4.5 years (range of 3.5 to 6.5 years). Six of these patients had accommodative esotropia, three had non-accommodative esotropia and five had exotropia. Following analysis, postoperative uncorrected Snellen visual acuity was found to be within one line of preoperative BCVA in all cases, and no patients suffered from diplopia at follow-up, Dr Farrell told the meeting.
There was also no significant difference between the angle of deviation preoperatively with spectacle correction and postoperatively unaided at follow-up in all groups. Stereoacuity decreased in one patient, increased in four patients and remained unchanged in nine patients.
Dr Farrell said the study confirmed the efficacy and safety of refractive surgery in this cohort over the longer term – no patients developed decompensation of strabismus or diplopia, and ocular alignment unaided remained similar to pre-operative ocular alignment with spectacles.
Safe and effective
“This study provides strong evidence that refractive surgery is safe and effective over the longer term. With a mean follow-up of 4.5 years this study provides longer follow-up than any other study published to date, “ he commented.
As well as refractive surgery providing all the benefits of being spectacle-free for these patients, it has now been found to be as effective as glasses at controlling strabismus over the longer term. “We would always stress the importance of careful patient selection and detailed orthoptic assessment preoperatively, however,” he remarked.
When asked about the potential for paediatric patients, he noted refractive surgery on children is usually for anisometropia rather than strabismus. “With longer follow-up of phakic intraocular lenses in children, they may in the future be an option for patients with strabismus, but given the changing nature of children's refraction spectacles are likely to remain the mainstay of treatment,” he told EuroTimes.
Latest Articles
ESCRS Today 2025: Happy Anniversaries!
ESCRS celebrates milestones with pioneers in IOLs, LASIK, femtosecond lasers, and corneal transplantation.
ESCRS Today 2025: A Congress for Everyone
From YOs to families, the ESCRS Annual Meeting embraces full participation through inclusivity.
Beyond the Numbers
Empowering patient participation fosters continuous innovation in cataract surgery.
Thinking Beyond the Surgery Room
Practice management workshop focuses on financial operations and AI business applications.
Aid Cuts Threaten Global Eye Care Progress
USAID closure leads retreat in development assistance.
Supplement: ESCRS Clinical Trends Series: Presbyopia
Debate: FS-LASIK or KLEx for Hyperopia?
FS-LASIK has more of a track record, but KLEx offers advantages.
Four AI Applications Ready for Practice
Commercial offerings may save time, improve practice and research.
Perioperative Medication Regimens for Cataract Surgery
Randomised controlled clinical trial results provide evidence-based guidance.